Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Sophocleous RA"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Animal Models for the Investigation of P2X7 Receptors.
Autorzy:
Sluyter R; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Adriouch S; UniRouen, INSERM, U1234, Pathophysiology, Autoimmunity, and Immunotherapy, (PANTHER), Univ Rouen Normandie, University of Rouen, F-76000 Rouen, France.
Fuller SJ; Sydney Medical School Nepean, Faculty of Medicine and Health, The University of Sydney, Nepean Hospital, Kingswood, NSW 2750, Australia.
Nicke A; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, 80336 Munich, Germany.
Sophocleous RA; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Watson D; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 04; Vol. 24 (9). Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Receptors, Purinergic P2X7*/genetics
Zebrafish*
Mice ; Rats ; Humans ; Animals ; Dogs ; Guinea Pigs ; Rabbits ; Macaca mulatta ; Models, Animal ; Mice, Knockout ; Adenosine Triphosphate
Czasopismo naukowe
Tytuł:
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.
Autorzy:
Cuthbertson P; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Elhage A; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Al-Rifai D; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Sophocleous RA; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Turner RJ; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Aboelela A; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sphinx University, Assiut 71515, Egypt.
Majed H; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Bujaroski RS; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Monash Institute of Pharmaceutical Science (ATMCF), Monash University, Parkville, VIC 3052, Australia.
Jalilian I; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Kelso MJ; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Watson D; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Buckley BJ; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Sluyter R; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2022 Sep 16; Vol. 12 (9). Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Purinergic P2X Receptor Antagonists*/pharmacology
Receptors, Purinergic P2X7*
Adenosine ; Adenosine Triphosphate/metabolism ; Amiloride/analogs & derivatives ; Amiloride/pharmacology ; Animals ; Dogs ; HEK293 Cells ; Humans ; Interleukin-1beta/metabolism ; Mice
Czasopismo naukowe
Tytuł:
The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.
Autorzy:
Sophocleous RA; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Ooi L; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Sluyter R; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 May 20; Vol. 23 (10). Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adenosine Triphosphate*/metabolism
Receptors, Purinergic P2X4*/genetics
Receptors, Purinergic P2X4*/metabolism
Humans ; Signal Transduction
Czasopismo naukowe
Tytuł:
P2Y 2 and P2X4 Receptors Mediate Ca Mobilization in DH82 Canine Macrophage Cells.
Autorzy:
Sophocleous RA; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Miles NA; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Ooi L; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Sluyter R; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 13; Vol. 21 (22). Date of Electronic Publication: 2020 Nov 13.
Typ publikacji:
Journal Article
MeSH Terms:
Calcium Signaling*
Calcium/*metabolism
Macrophages/*metabolism
Receptors, Purinergic P2X4/*metabolism
Receptors, Purinergic P2Y2/*metabolism
Animals ; Cell Line ; Dogs ; Macrophages/cytology ; Purinergic P2X Receptor Antagonists/pharmacology ; Purinergic P2Y Receptor Antagonists/pharmacology
Czasopismo naukowe
Tytuł:
Pharmacological and genetic characterisation of the canine P2X4 receptor.
Autorzy:
Sophocleous RA; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Berg T; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Finol-Urdaneta RK; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Electrophysiology Facility for Cell Phenotyping and Drug Discovery, Wollongong, NSW, Australia.
Sluyter V; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Keshiya S; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Bell L; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Curtis SJ; Albion Park Veterinary Hospital, Albion Park, NSW, Australia.
Curtis BL; Albion Park Veterinary Hospital, Albion Park, NSW, Australia.
Seavers A; Oak Flats Veterinary Clinic, Oak Flats, NSW, Australia.
Bartlett R; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Dowton M; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Stokes L; School of Pharmacy, University of East Anglia, Norwich, UK.
Ooi L; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Sluyter R; Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2020 Jun; Vol. 177 (12), pp. 2812-2829. Date of Electronic Publication: 2020 Mar 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Purinergic P2X Receptor Antagonists*
Receptors, Purinergic P2X4*/genetics
Adenosine Triphosphate ; Animals ; Dogs ; HEK293 Cells ; Humans ; Receptors, Purinergic P2X7
Czasopismo naukowe
Tytuł:
Association of a P2RX7 gene missense variant with brachycephalic dog breeds.
Autorzy:
Sophocleous RA; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Sluyter V; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Curtis BL; Albion Park Veterinary Hospital, Albion Park, NSW, 2527, Australia.
Curtis SJ; Albion Park Veterinary Hospital, Albion Park, NSW, 2527, Australia.
Jurak LM; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Faulks M; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Spildrejorde M; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Gates S; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Proctor EJ; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Seavers A; Oak Flats Veterinary Clinic, Oak Flats, NSW, 2529, Australia.
Watson D; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Kuit T; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Dowton M; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Stokes L; School of Pharmacy, University of East Anglia, Norwich, NR4 7TJ, UK.
Sluyter R; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.
Pokaż więcej
Źródło:
Animal genetics [Anim Genet] 2020 Feb; Vol. 51 (1), pp. 127-131. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation, Missense*
Craniosynostoses/*veterinary
Dog Diseases/*genetics
Dogs/*genetics
Receptors, Purinergic P2X7/*genetics
Animals ; Breeding ; Craniosynostoses/genetics ; Pedigree
Czasopismo naukowe
Tytuł:
Ferlins Show Tissue-Specific Expression and Segregate as Plasma Membrane/Late Endosomal or Trans-Golgi/Recycling Ferlins.
Autorzy:
Redpath GM; Institute for Neuroscience and Muscle Research, Kid's Research Institute, Children's Hospital at Westmead, Sydney, Australia.; Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
Sophocleous RA; Institute for Neuroscience and Muscle Research, Kid's Research Institute, Children's Hospital at Westmead, Sydney, Australia.
Turnbull L; Microbial Imaging Facility, The iThree Institute, University of Technology Sydney, Ultimo, Australia.
Whitchurch CB; Microbial Imaging Facility, The iThree Institute, University of Technology Sydney, Ultimo, Australia.
Cooper ST; Institute for Neuroscience and Muscle Research, Kid's Research Institute, Children's Hospital at Westmead, Sydney, Australia.; Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
Pokaż więcej
Źródło:
Traffic (Copenhagen, Denmark) [Traffic] 2016 Mar; Vol. 17 (3), pp. 245-66.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium-Binding Proteins/*metabolism
Cell Membrane/*metabolism
Endosomes/*metabolism
Membrane Proteins/*metabolism
Muscle Proteins/*metabolism
trans-Golgi Network/*metabolism
Amino Acid Sequence ; Animals ; Brain/metabolism ; COS Cells ; Calcium-Binding Proteins/chemistry ; Calcium-Binding Proteins/genetics ; Chlorocebus aethiops ; HEK293 Cells ; Humans ; Membrane Proteins/chemistry ; Membrane Proteins/genetics ; Mice ; Molecular Sequence Data ; Muscle Proteins/chemistry ; Muscle Proteins/genetics ; Organ Specificity ; Pancreas/metabolism ; Protein Transport ; rab GTP-Binding Proteins/metabolism
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies